UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
June 10, 2010
Date of Report (Date of Earliest Event Reported)
________________________
POLYMEDIX, INC.
(Exact name of registrant as specified in its charter)
_____________________
Delaware | 000-51895 | 27-0125925 |
(State or other jurisdiction
of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| | |
170 N. Radnor Chester Road, Suite 300 Radnor, Pennsylvania | | 19087 |
(Address of principal executive offices) | | (Zip Code) |
(448) 598-2400
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or address, if changed since last report)
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07 Submission of Matters to a Vote of Security Holders
At the Annual Meeting of Stockholders of PolyMedix, Inc. (the “Company”) held on June 10, 2010, the stockholders elected Nicholas Landekic, Frank Slattery, Jr., Brian Anderson, Richard W. Bank, M.D., Michael E. Lewis, Ph.D., Stefan D. Loren, Ph.D., Shaun F. O’Malley and Douglas J. Swirsky as directors to serve one-year terms expiring at the 2011 Annual Meeting of Stockholders. Stockholders also approved the ratification of Deloitte & Touche LLP as the Company’s independent auditor for the year ending December 31, 2010.
Following are the voting results:
Proposal 1. Election of Directors
Nominee | For | Withheld | Broker Non-Votes |
Nicholas Landekic | 19,992,400 | 124,780 | - |
Frank Slattery, Jr. | 19,941,043 | 176,137 | - |
Brian Anderson | 16,054,960 | 4,062,220 | - |
Richard W. Bank, M.D. | 16,049,960 | 3,067,220 | - |
Michael E. Lewis, Ph.D. | 20,011,780 | 105,400 | - |
Stefan D. Loren, Ph.D. | 16,052,960 | 4,064,220 | - |
Shaun F. O’Malley | 15,986,460 | 4,130,720 | - |
Douglas J. Swirsky | 15,969,900 | 4,141,280 | - |
Proposal 2. Ratification of Independent Auditors
For | Against | Abstain | Broker Non-Votes |
42,510,663 | 116,878 | 222,813 | - |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | POLYMEDIX, INC. |
| | |
June 14, 2010 | | /s/ Edward F. Smith |
| | Edward F. Smith |
| | Vice President, Finance and Chief Financial Officer |
